Health status during hospitalisations for chronic obstructive pulmonary disease exacerbations: The validity of the Clinical COPD Questionnaire

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 14, Issue 2, 2014, Pages 283-287

  Antoniu, Sabina A ^a   Puiu, Alina ^b   Zaharia, Bogdan ^c   Azoicai, Doina ^a  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Regional Institute of Oncology   (Romania)

^c Centre Hospitalier Auxerre   (France)

Author keywords

Chronic obstructive pulmonary disease; Clinical COPD Questionnaire; Exacerbations; Health related quality of life; Hospitalizations for COPD exacerbations; Questionnaires; Respiratory; Symptoms

Indexed keywords

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY QUESTIONNAIRE; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; HEALTH STATUS; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT REPEATABILITY; PROSPECTIVE STUDY; QUALITY OF LIFE; RELIABILITY; VALIDATION STUDY; MIDDLE AGED; PSYCHOLOGY; QUESTIONNAIRE;

AGED; FEMALE; HEALTH STATUS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES;

EID: 84896299785     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/14737167.2014.887446     Document Type: Article

References (22)

1. Global I for chronic obstructive pulmonary disease. Global Strategy for Diagnosis, Management, and Prevention of COPD; 2011 Update
2. Spencer S. Health status measurement in exacerbations of COPD. Expert Rev Respir Med 2009;3(6):573-83
3. Global I for chronic obstructive pulmonary disease. Global Strategy for Diagnosis, Management, and Prevention of COPD; 2013 Update
4. Kocks JW, van der Molen T. Risk indexes for COPD exacerbations II. Chest 2007; 131(6):1986-7.author reply 1987
5. Jones PW. Health status: what does it mean for payers and patients? Proc Am Thorac Soc 2006;3(3):222-6
6. Antoniu SA. Effects of inhaled therapies on health-related quality of life in stable chronic obstructive pulmonary disease. Expert Rev Pharmacoecon Outcomes Res 2010;10(2):155-62
7. Trappenburg J, Touwen I, de Weert-van Oene GH, et al. Detecting exacerbations using the Clinical COPD Questionnaire. Health Qual Life Outcomes 2010;8(1):102
8. Ställberg B, Nokela M, Ehrs PO, et al. Validation of the clinical COPD Questionnaire (CCQ) in primary care. Health Qual Life Outcomes 2009;7:26
9. Bech P, Gudex C, Johansen KS. The WHO (Ten) Well-Being Index: validation in diabetes. Psychother Psychosom 1996;65: 183-90
10. Lucas-Carrasco R, Allerup P, Bech P. The validity of the WHO-5 as an early screening for apathy in an elderly population. Curr Gerontol Geriatr Res 2012;2012:171857
11. Witek TJ Jr, Mahler DA. Minimal important difference of the transition dyspnoea index in a multinational clinical trial. Eur Respir J 2003;21(2):267-72
12. Rutten-van Mölken MP, Oostenbrink JB, Tashkin DP, et al. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest 2006;130(4):1117-28
13. Mahler DA, Weinberg DH, Wells CK, et al. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984;85(6):751-8
14. Bech P. Measuring the dimensions of psychological general well-being by the WHO-5. QoL Newsletter 2004;32:15-16
15. van der Molen T, Willemse BW, Schokker S, et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003;1:13
16. Kocks JW, Tuinenga MG, Uil SM, et al. Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res 2006;7:62
17. Miravitlles M, Izquierdo I, Herrejón A, et al. COPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA study. Respir Med 2011; 105(5):740-7
18. Xu W, Collet JP, Shapiro S, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med 2008;178(9):913-20
19. Aaron SD, Vandemheen KL, Clinch JJ, et al. Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation. Chest 2002;121(3):688-96
20. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145(6):1321-7
21. Tsai CL, Hodder RV, Page JH, et al. The short-form chronic respiratory disease questionnaire was a valid, reliable, and responsive quality-of-life instrument in acute exacerbations of chronic obstructive pulmonary disease. J Clin Epidemiol 2008; 61(5):489-97
22. Mackay AJ, Donaldson GC, Patel AR, et al. Usefulness of the chronic obstructive pulmonary disease assessment test to evaluate severity of COPD exacerbations. Am J Respir Crit Care Med 2012;185(11): 1218-24